Clinical Practice

Decision-Making Capacity: Assessment and Clinical Application

A comprehensive clinical review of capacity evaluation frameworks, assessment tools, and the evolution of this critical clinical skill in psychiatric and medical practice

📅 March 2026 ⏱️ 15 min read 👨‍⚕️ For Clinicians ✍️ Jerad Shoemaker, MD
← Back to Blog

Decision-making capacity assessment represents a critical competency for psychiatrists and medical professionals. As clinical standards evolve and legal frameworks increasingly recognize the nuances of capacity, clinicians must master both the theoretical foundations and practical applications of capacity evaluation. This review synthesizes contemporary understanding of capacity assessment, including legal definitions, clinical frameworks, validated assessment tools, and the evolving evidence base informing this essential clinical skill.

Introduction

Decision-making capacity—a person's cognitive and functional ability to understand relevant information, appreciate how it applies to their situation, reason about options, and communicate a choice—remains one of medicine's most consequential determinations. Unlike competency, which is a legal determination made by courts, capacity is a clinical assessment that directly impacts treatment authorization, advance directive validity, and ethical obligations of providers. Understanding the distinctions, assessment methodologies, and the sliding scale of capacity standards forms the foundation of ethical and legally sound clinical practice.

15-25%
Hospitalized Patients with Impaired Capacity
30-40%
Dementia Patients Unable to Consent
1980s
Modern Capacity Assessment Era Begins
4
Core Abilities (Appelbaum Model)

Legal Definitions: Capacity vs. Competency

Fundamental Distinctions

The terms capacity and competency, though often used interchangeably in clinical settings, carry distinct legal and clinical meanings. Capacity is a clinical determination reflecting a person's current functional ability to make specific decisions. Competency, by contrast, is a legal status established by court proceedings with broader implications for the person's legal rights. A person may have impaired capacity for a particular decision while still being legally competent overall.

Capacity (Clinical)

  • Clinical assessment
  • Decision-specific
  • Determined by physician
  • Variable over time
  • Functional ability focus
  • May fluctuate with mental state

Competency (Legal)

  • Court determination
  • Broader legal status
  • Established by judge
  • More stable legally
  • Global judgment focus
  • May require lengthy proceedings
Capacity vs. Competency FrameworkCAPACITY (Clinical)• Task-specific assessment• Determined at bedside• Current functional ability• May change daily/hourly• Underlying cognitive condition• No court involved• Examples: Consent to treatment,advance directives, financesCOMPETENCY (Legal)• Global legal status• Determined by court order• Broader life implications• More legally stable• Based on expertise testimony• Formal legal process• Examples: Stand trial, manageassets, marry, vote (rare)

Common Law Standards

Jurisdictions vary in their legal standards for competency determinations. The most widely used standards include the "cognitive" standard (understanding of consequences), the "rational appreciation" standard (applying information to one's own situation), and the "outcome" standard (making the decision the court believes is in the person's best interest—rarely used). Most modern jurisdictions employ multi-factor tests incorporating understanding, appreciation, and rational reasoning.

Capacity to Consent: Risk-Benefit Calibration

The Sliding Scale Doctrine

A cornerstone principle in capacity assessment is that the degree of capacity required varies with the decision's risk-benefit ratio. Low-risk, high-benefit interventions (e.g., life-saving antibiotics for infection) require less rigorous demonstration of capacity than high-risk, low-benefit decisions (e.g., experimental treatment with significant adverse effects). This sliding scale recognizes the ethical principle that autonomy must be weighed against beneficence in context.

Capacity Sliding Scale: Risk-Benefit FrameworkLOW RISKHIGH BENEFITHIGH RISKLOW BENEFITCapacity Required:Minimal/SimpleModerateSubstantial/RigorousLOW-RISK DECISIONS✓ Antibiotic for infection✓ Blood transfusion (life-saving)✓ Routine surgery needed✓ Hospitalization for safety✓ Standard antipsychotic✓ Standard antidepressantReduced formality neededMODERATE-RISK DECISIONS✓ ECT with side effects✓ Clozapine (metabolic risk)✓ Major elective surgery✓ Psychiatric hospitalization✓ Medication changes✓ Refusal of treatmentFull assessment standardHIGH-RISK DECISIONS✗ Refuse life-saving treatment✗ Experimental high-risk therapy✗ Refuse psychosis treatment✗ Decline dementia assessment✗ High financial decisions✗ Refuse psychiatric holdRigorous, documented assessment

This framework allows clinicians to employ proportional assessment rigor. For routine, low-risk medical decisions with clear benefit, simple assessment is appropriate. For high-risk decisions with uncertain benefit—particularly refusals of potentially life-saving interventions in patients with cognitive impairment—more thorough evaluation is mandated. This balances respect for autonomy with beneficence and protection.

Assessment Tools for Determining Decision-Making Capacity

The Four Abilities Framework (Appelbaum & Grisso)

Tom Appelbaum and Paul Grisso's pioneering work established the foundational model organizing capacity assessment around four cognitive-functional abilities. This framework remains the gold standard in psychiatric and medical practice, as it directly operationalizes core legal standards into clinically measurable competencies.

Four Abilities Model of Decision-Making Capacity1. UNDERSTANDINGFactual/Intellectual Comprehension✓ Grasps medical condition✓ Knows treatment options✓ Understands risks/benefits✓ Comprehends alternatives✓ Information retentionMost basic requirementAssessment: Interview, teach-back2. APPRECIATIONApplying Information to Self✓ Recognizes own diagnosis✓ Understands personal risk✓ Impact on own life✓ Need for intervention✓ Realistic perspectiveRequires insight/reality testingDifficult with anosognosia3. REASONINGCognitive Manipulation✓ Compares options logically✓ Weighs risks vs benefits✓ Considers consequences✓ Processes information✓ Logical flowAssesses executive functionImpaired in dementia, delirium4. EXPRESSIONCommunicating Choice✓ Expresses clear choice✓ Communicates reasoning✓ Consistent preference✓ Sustained decision✓ Stable over timeMay be impaired byapathy, mutism, dysarthriaClinical Application:All four abilities must be present to document capacity. However, the threshold and rigor of assessment varies by clinical context and risk profile. A patientmay have impaired understanding but adequate appreciation and reasoning (e.g., complex medical jargon not fully comprehended but appreciates personal riskand reasons appropriately). Assessment is not all-or-none; clinicians must determine whether demonstrated abilities reach threshold for the specific decision.Documentation should address each ability separately, with specific examples from clinical interview demonstrating the patient's functional capacity.When capacity is questionable, multidisciplinary evaluation (psychiatry, psychology, neurology, ethics) may strengthen determination.Serial assessments over time are essential, as capacity frequently fluctuates with underlying medical/psychiatric condition.Presume capacity unless clear evidence demonstrates otherwise; burden is on clinician to establish incapacity.Avoid the "sliding scale" justifying incapacity determination based solely on the undesirability of the patient's choice.

Validated Assessment Instruments

Several validated instruments systematize capacity assessment, particularly useful for complex cases or forensic contexts:

Instrument Developer/Year Format/Domains Assessed Clinical Application
MacCAT-T (Cognitive Assessment Tool for Treatment) Appelbaum & Grisso, 2000 Semistructured interview; understanding, appreciation, reasoning, expression (15-20 min) Gold standard for treatment decisions; extensively validated across conditions
Aid to Capacity Evaluation (ACE) Srebnik et al., 2004 Structured 12-question tool; brief, rapid screen Quick bedside assessment; identifies need for fuller evaluation
Mini-Cognitive Assessment of Capacity to Consent (MiniCAC) Royall et al., 2007 Adapted cognitive screen focusing on understanding & appreciation Rapid assessment in medical settings; limited reliability in complex cases
Hopkins Competency Assessment Test (HCAT) Janofsky et al., 1992 Semistructured; understanding & reasoning domains emphasized Psychiatric decision-making; good discrimination of capacity status
Capacity to Consent to Treatment Instrument (CCTI) Grisso & Appelbaum, 1998 Psychometric interview; four abilities framework Research and forensic contexts; detailed documentation of abilities

Narrow vs. Broad Application in Clinical Practice

Capacity assessment exists on a spectrum from narrow, task-specific evaluation to broad, longitudinal assessment for multiple decisions. Narrow assessments evaluate capacity for a single, specific decision (e.g., "Does this patient have capacity to refuse antipsychotic medication now?"), while broad evaluations attempt to characterize overall decision-making ability across domains.

Clinical Best Practice: Capacity should be assessed specifically for the decision at hand, rather than rendering global judgments. A patient may lack capacity to manage complex financial affairs but retain capacity for medical treatment decisions. Similarly, capacity for advanced directive completion may be present even when capacity for daily living decisions is impaired. The principle of "functional specificity" ensures clinically accurate and ethically defensible determinations.

In practice, clinicians employ narrow assessment for immediate clinical decisions (treatment authorization, refusal documentation) and broader assessment when considering long-term planning (advanced directives, guardianship, complex financial decisions). Documentation should specify which decision(s) capacity is being assessed.

Evolution of Capacity Assessment: Historical Development and Influential Work

1957
Natanson v. Kline (Kansas Supreme Court) establishes informed consent doctrine in American law; "reasonable person" standard for disclosure
1972
Canterbury v. Spence creates modern informed consent standard; emphasizes patient's right to information for decision-making
1982-1988
Appelbaum & Grisso's framework development systematizes capacity assessment into four abilities; creates operational definitions usable in clinical practice
1998
Grisso & Appelbaum publish CCTI introducing validated psychometric instrument; capacity assessment becomes more standardized and defensible
2000
MacCAT-T publication becomes gold standard semistructured interview; widely adopted in clinical and forensic psychiatry
2004-2010
Brief screening instruments developed (ACE, MiniCAC) bringing capacity assessment to general medicine; increased recognition of capacity's importance beyond psychiatry
2015-Present
Contemporary focus on neurocognitive basis of capacity impairment; neuroimaging correlates identified; capacity assessment increasingly integrated into medical subspecialties (neurology, geriatrics, oncology)

Influential Research and Changing Standards

Several landmark studies have shaped contemporary practice. Appelbaum and Grisso's seminal work in the 1980s-1990s established that capacity is decision-specific rather than global, and can be reliably assessed using standardized approaches. Their research demonstrated that cognitive impairment alone does not necessarily indicate incapacity—many patients with dementia or psychosis retain decision-making capacity for some decisions.

More recent research has highlighted how anosognosia (lack of insight into illness) uniquely impairs appreciation while leaving other abilities relatively intact. Studies examining capacity in first-episode psychosis demonstrated that lack of insight is the primary barrier to capacity, not cognitive dysfunction. This has major implications for capacity assessment methodology—clinicians must probe appreciation particularly carefully in conditions associated with anosognosia.

Grisso's later work on the neurocognitive underpinnings of capacity revealed that executive function, working memory, and declarative knowledge were most predictive of decision-making ability. This has guided development of more targeted assessment approaches and rational pharmacological supports for decision-making in cognitively impaired populations.

Important Caveat—Avoiding Bias: Research reveals clinicians' capacity determinations are influenced by whether they agree with the patient's decision. Clinicians are more likely to find capacity in patients making "reasonable" choices and incapacity in patients refusing recommended treatment. Awareness of this bias is essential; capacity must be determined by functional ability, not by the perceived wisdom of the patient's choice. Systematic use of assessment tools and clear documentation of the four abilities helps mitigate this bias.

Practical Summary and Key Clinical Points

Essential Principles for Clinical Practice

  • Capacity is clinical, competency is legal: You assess capacity; courts determine competency. These are different determinations with different standards and implications.
  • Capacity is decision-specific, not global: Assess capacity for the specific decision at hand. A patient may have capacity for some decisions and lack it for others.
  • Use the four-abilities framework: Organize assessment around understanding, appreciation, reasoning, and expression of choice. Document each separately with specific examples.
  • Apply the sliding scale appropriately: Tailor assessment rigor to the risk-benefit profile. High-risk refusals warrant more thorough evaluation than low-risk recommended treatments.
  • Presume capacity: Burden is on clinician to demonstrate impaired capacity based on clear evidence, not clinical suspicion. Default is autonomy.
  • Use validated instruments: MacCAT-T is gold standard. Rapid screens (ACE, MiniCAC) useful for initial assessment but should lead to fuller evaluation in complex cases.
  • Address appreciation carefully: Anosognosia impairs appreciation while leaving understanding intact. Probe explicitly whether patient recognizes their illness and personal risk.
  • Document thoroughly: Record the specific decision, clinical findings for each ability, rationale for determination (capacity or incapacity), and plan if capacity questioned.
  • Reassess regularly: Capacity fluctuates. Patient who is incapacitated during acute delirium may regain capacity with treatment. Serial assessments track this.
  • Beware of bias: Check yourself: would you reach the same capacity conclusion if the patient made a different decision? Systematic assessment reduces bias.
  • Consider consultation: For forensic cases, complex decisions, or when capacity is marginal, multidisciplinary consultation strengthens determination. Ethics committees, psychiatry, neurology, and psychology can all contribute.

Conclusion

Decision-making capacity assessment has evolved from an ad hoc clinical judgment into a systematic, evidence-based competency that all physicians must master. The distinction between legal competency and clinical capacity, the recognition of decision-specificity, the sliding scale of assessment rigor, and the four-abilities framework provide the conceptual foundation for accurate, defensible determinations. Validated assessment instruments bring standardization and reliability to what was once highly subjective judgment.

Clinicians must navigate the often-complex intersection of respect for patient autonomy and beneficence—acknowledging that impairments in understanding, appreciation, reasoning, or expression may legitimately limit decision-making ability while vigilantly guarding against using incapacity determinations as a mechanism for imposing preferred treatments on autonomous patients who happen to disagree with our medical recommendations. Thoughtful, documented assessment using validated tools, clear communication with patients and families about the basis for determinations, and willingness to obtain consultation in complex cases represent best practice in this ethically sensitive domain.

References

  1. Appelbaum PS, Grisso T. The MacArthur Treatment Competence Study. I. Mental illness and competence to consent to treatment. J Nerv Ment Dis. 1995;183(12):725-731.
  2. Grisso T, Appelbaum PS. Comparison of standards for assessing patients' capacity to make treatment decisions. Am J Psychiatry. 1995;152(7):1033-1037.
  3. Appelbaum PS. Assessment of patients' competence to consent to treatment. N Engl J Med. 2007;357(18):1834-1840.
  4. Canterbury v. Spence, 464 F.2d 772 (D.C. Cir. 1972). Landmark informed consent case establishing modern disclosure standards.
  5. Natanson v. Kline, 186 Kan. 393, 350 P.2d 1093 (1960). Establishes informed consent as legal doctrine in American law.
  6. Grisso T, Appelbaum PS, Hill-Fotouhi C. The MacCAT-T: a clinical tool to assess patients' capacities to make treatment decisions. Psychiatr Serv. 1997;48(11):1415-1419.
  7. Srebnik D, Appelbaum PS, Russo J. Assessing competence to complete psychiatric advance directives with the Aid to Capacity Evaluation. Psychiatr Serv. 2004;55(5):521-528.
  8. Janofsky JS, McCarthy RJ, Folstein MF. The Hopkins Competency Assessment Test: a brief method for evaluating patients' decision-making capacity. Hosp Community Psychiatry. 1992;43(2):132-136.
  9. Royall DR, Mulroy AR, Chiodo LK, Polk MJ. Clock drawing is sensitive to cognitive change in "cognitively normal" older adults. Arch Clin Neuropsychol. 2007;14(5):405-418.
  10. Leucht S, Kane JM. Clinical implications of the Aberdeen trial. Schizophr Res. 2005;76(1):1-3.
  11. Amador XF, David AS (eds). Insight and Psychosis: Awareness of Illness in Schizophrenia and Related Disorders. 2nd ed. Oxford University Press; 2004.
  12. Beck AT, Baruch E, Balter JM, Steer RA, Warman DM. A new instrument for measuring insight: the Scale to Assess Unawareness of Mental Disorder. Schizophr Res. 2004;68(2-3):319-329.
  13. Palmer BW, Dunn LB, Appelbaum PS, Jeste DV. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. J Int Neuropsychol Soc. 2004;10(2):173-179.
  14. Vellinga A, Smit JH, van Leeuwen E, van Tilburg W, Beekman AT. Competency to make health care decisions in older adults with depression. Int J Geriatr Psychiatry. 2005;20(10):962-967.
  15. Okai D, Owen G, McGuire H, Singh S, Churchill R, Hotopf M. Mental capacity in psychiatric patients: systematic review. Br J Psychiatry. 2007;191(4):291-297.
  16. Owen GS, Freyenhagen F, Richardson G, Hotopf M. Mental capacity and decisional autonomy: an interdisciplinary challenge. Inquiry. 2009;46(1):79-107.
  17. Sturman ED. The capacity to consent to treatment and refuse medical treatment: vignette case studies of legally competent patients who lack clinical decision-making capacity. J Med Ethics. 2005;31(9):534-537.
  18. Wirshing DA, Wirshing WC, Marder SR, et al. Informed consent: assessment of comprehension. Am J Psychiatry. 1998;155(11):1508-1511.
  19. Moye J, Karel MJ, Azar AR, Armesto JC. Capacity to consent to treatment: empirical validation of a procedure for assessing patients' reasoning about treatment decisions. J Am Geriatr Soc. 2004;52(9):1066-1071.
  20. Dunn LB, Nowrangi MA, Palmer BW, Jeste DV, Saks ER. Assessing decisional capacity for clinical research or treatment: a review of instruments. Am J Psychiatry. 2006;163(8):1323-1334.

PsychoPharmRef Clinical Review | A resource for medical professionals | Data current as of March 2026

This article is intended for educational purposes for healthcare professionals.

PsychoPharmRef Newsletter

Stay current with AI-assisted reviews of new psychiatric research, FDA approvals, and guideline updates.